Skip to content
healthcare.dev

Fexofenadine HCL

NDC 68788-7449, Fexofenadine HCL, tablet, from Preferred Pharmaceuticals, Inc..

Product NDC
68788-7449
Status
Listed
Labeler
Preferred Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA204097
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68788-7449 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FEXOFENADINE HYDROCHLORIDE180 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
68788-7449-168788744901100 TABLET in 1 BOTTLE (68788-7449-1)
68788-7449-36878874490330 TABLET in 1 BOTTLE (68788-7449-3)
68788-7449-66878874490660 TABLET in 1 BOTTLE (68788-7449-6)
68788-7449-96878874490990 TABLET in 1 BOTTLE (68788-7449-9)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 68788-7449 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68788-7449 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68788-7449. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.